Nov
DEC
Jan
20
2014
2015
2016
1 captures
20 Dec 15 - 20 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Rheumatoid Arthritis
Infliximab Biosimilar Appears Safe and Effective Compared with Infliximab for RA
Flare-Free Withdrawal of TNFis Possible in Patients with RA and Stable Low Disease Activity
Triple Therapy More Cost-effective than Biologic First in Patients Who Fail MTX
GR Agonist Improves Responses in RA
Preventing GC-Induced Bone Loss in Women with RA
Highlights of the Latest Pediatric Rheumatology Research
The Role of Biosimilar and Orphan Drugs in Treating Patients with Rheumatologic Disease
Oral Steroids Should Be Avoided in Patients with RA and ILD
Study Confirms Biosimilarity of HD203 and Etanercept in Patients with RA
BOW-015 is Biosimilar to Infliximab with Respect to Efficacy and Safety
Pages
Next
1
2
3